|
|
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date29 Oct 2019 |
|
|
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date27 Mar 2013 |
|
MechanismCD49d antagonists |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date23 Nov 2004 |
100 Clinical Results associated with Biogen Australia Pty Ltd.
0 Patents (Medical) associated with Biogen Australia Pty Ltd.
100 Deals associated with Biogen Australia Pty Ltd.
100 Translational Medicine associated with Biogen Australia Pty Ltd.